![Robert J. Depasqua](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert J. Depasqua
Direktor/Vorstandsmitglied bei Audax Medical, Inc.
Profil
Robert J.
Depasqua is currently a Director at Audax Medical, Inc. Previously, he worked as a Director at Cambridge Heart, Inc. He obtained an undergraduate degree from Northeastern University.
Aktive Positionen von Robert J. Depasqua
Unternehmen | Position | Beginn |
---|---|---|
Audax Medical, Inc.
![]() Audax Medical, Inc. Medical SpecialtiesHealth Technology Audax Medical, Inc. operates as an orthopedic company that focuses on the development of a regenerative biomaterial. It develops Arxis, a self-assembling bioresorbable nanocomposite that can be used in minimally-invasive orthopedic reconstructive surgery. The company was founded by Mark A. Johanson, Christopher J. P. Velis in 2009 and is headquartered in Concord, MA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Robert J. Depasqua
Unternehmen | Position | Ende |
---|---|---|
CAMBRIDGE HEART, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Robert J. Depasqua
Northeastern University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Cambridge Heart, Inc.
![]() Cambridge Heart, Inc. Medical SpecialtiesHealth Technology Cambridge Heart, Inc. engages in the development and commercialization of products for the non-invasive diagnosis of cardiac disease. The company was founded by Jeffrey M. Arnold and Jordan S. Davis on January 16, 1990 and is headquartered in Tewksbury, MA. | Health Technology |
Audax Medical, Inc.
![]() Audax Medical, Inc. Medical SpecialtiesHealth Technology Audax Medical, Inc. operates as an orthopedic company that focuses on the development of a regenerative biomaterial. It develops Arxis, a self-assembling bioresorbable nanocomposite that can be used in minimally-invasive orthopedic reconstructive surgery. The company was founded by Mark A. Johanson, Christopher J. P. Velis in 2009 and is headquartered in Concord, MA. | Health Technology |